Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community

International Journal of Epidemiology

Volumn 43, Issue 4, 2014, Pages 1114-1122

  Middelkoop, Keren ^a   Bekker, Linda Gail ^a   Mathema, Barun ^b,c   Myer, Landon ^a   Shashkina, Elena ^c   Whitelaw, Andrew ^a,d   Kurepina, Natalia ^c   Kaplan, Gilla ^c   Kreiswirth, Barry ^c   Wood, Robin ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Mailman School of Public Health   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Epidemiology; Molecular; Polymorphism; Pulmonary; Restriction fragment length; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ISONIAZID; RIFAMPICIN; ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; DEMOGRAPHY; FEMALE; GENOTYPE; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROBIAL DIVERSITY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; SOCIAL ASPECT; SOUTH AFRICA; SPUTUM; TREATMENT OUTCOME; GENETICS; HIV INFECTIONS; INFANT; MICROBIOLOGY; MIDDLE AGED; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; PRESCHOOL CHILD; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SOUTH AFRICA; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84905648546     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyu044     Document Type: Article

References (27)

1. World Health Organization. Global Tuberculosis Report. 2012. http://apps.who.int/iris/bitstream/10665/75938/1/978924156 4502_eng.pdf (27 November 2013, date last accessed).
2. Williams BG. TB and HIV: deadly liaison or manageable threat? Sci Transl Med 2012;4:135 fs15.
3. Warren R, Hauman J, Beyers N et al. Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high-incidence community. S Afr Med J 1996;86:45-49.
4. van der Spuy GD, Kremer K, Ndabambi SL et al. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinb) 2009;89: 120-25.
5. Lockman S, Sheppard JD, Braden CR et al. Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol 2001;39:1042-47.
6. Verver S, Warren RM, Munch Z et al. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 2004;33:351-57.
7. Glynn JR, Crampin AC, Traore H et al. Determinants of cluster size in large, population-based molecular epidemiology study of tuberculosis, northern Malawi. Emerg Infect Dis 2008;14: 1060-66.
8. Glynn JR, Alghamdi S, Mallard K et al. Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi. PLoS One 2010;5:e12259.
9. Wood R, Middelkoop K, Myer L et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007;175:87-93.
10. Middelkoop K, Bekker LG, Myer L et al. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011;56:263-69.
11. Middelkoop K, Bekker LG, Myer L et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South african township. Am J Respir Crit Care Med 2010;182: 1080-85.
12. Department of Health Republic of South Africa. National Tuberculosis Management Guidelines. 2009; http://familymedicine. ukzn.ac.za/Libraries/Guidelines_Protocols/TB_Guidelines_ 2009.sflb.ashx (27 November 2013, date last accessed).
13. Health Systems Trust. Cape Town TB Control. Progress report 1997-2003. 2004. www.hst.org.za./publications/618 (27 November 2013, date last accessed).
14. van Embden JD, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-09.
15. Bifani PJ, Mathema B, Liu Z et al. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999;282:2321-27.
16. Gutacker MM, Mathema B, Soini H et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis 2006;193:121-28.
17. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006;19:658-85.
18. Cox DR, Stuart A. Some quick sign tests for trend in location and dispersion. Biometrika 1955;42:80-95.
19. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007;7:328-37.
20. Middelkoop K, Bekker LG, Liang H et al. Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study. BMC Infect Dis 2011;11:156.
21. Mathema B, Kurepina N, Yang G et al. Epidemiologic consequences of microvariation in Mycobacterium tuberculosis. J Infect Dis 2012;205:964-74.
22. Hanekom M, van der Spuy GD, Streicher E et al. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol 2007;45:1483-90.
23. Wu S, Barnes PF, Samten B et al. Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth. Microbiology 2009;155:1272-81.
24. de Jong BC, Hill PC, Aiken A et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 2008;198:1037-43.
25. Luciani F, Sisson SA, Jiang H, Francis AR, Tanaka MM. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2009;106:14711-15.
26. Kruuner A, Hoffner SE, Sillastu H et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001;39: 3339-45.
27. Middelkoop K, Bekker LG, Shashkina E, Kreiswirth B, Wood R. Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. Int J Tuberc Lung Dis 2012;16:1510-16